Genetic basis of Alzheimer's dementia: role of mtDNA mutations

Genes Brain Behav. 2006:5 Suppl 2:92-107. doi: 10.1111/j.1601-183X.2006.00225.x.

Abstract

Alzheimer's disease (AD) is the most common neurodegenerative disorder associated to dementia in late adulthood. Amyloid precursor protein, presenilin 1 and presenilin 2 genes have been identified as causative genes for familial AD, whereas apolipoprotein E epsilon4 allele has been associated to the risk for late onset AD. However, mutations on these genes do not explain the majority of cases. Mitochondrial respiratory chain (MRC) impairment has been detected in brain, muscle, fibroblasts and platelets of Alzheimer's patients, indicating a possible involvement of mitochondrial DNA (mtDNA) in the aetiology of the disease. Several reports have identified mtDNA mutations in Alzheimer's patients, suggesting the existence of related causal factors probably of mtDNA origin, thus pointing to the involvement of mtDNA in the risk contributing to dementia, but there is no consensual opinion in finding the cause for impairment. However, mtDNA mutations might modify age of onset, contributing to the neurodegenerative process, probably due to an impairment of MRC and/or translation mechanisms.

Publication types

  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Alzheimer Disease / complications
  • Alzheimer Disease / genetics*
  • Alzheimer Disease / metabolism
  • Amyloid beta-Peptides / genetics*
  • Amyloid beta-Peptides / metabolism
  • Animals
  • Base Sequence
  • DNA, Mitochondrial / genetics*
  • Humans
  • Mice
  • Mitochondrial Diseases / complications
  • Mitochondrial Diseases / genetics*
  • Mitochondrial Diseases / metabolism
  • Molecular Sequence Data
  • Mutation / genetics*
  • NADH Dehydrogenase / genetics
  • Primates / genetics
  • Risk Factors
  • Sequence Homology

Substances

  • Amyloid beta-Peptides
  • DNA, Mitochondrial
  • NADH Dehydrogenase